IQ20/20 Supports Emerging Biopharma’s First Launch

4 Pages

An EBP preparing its first neurology drug launch lacked infrastructure for analytics. IQVIA deployed its IQ20/20 BI platform to integrate sales, prescribing, CRM, and distribution data into actionable insights. Despite the COVID-19 pandemic, the launch exceeded expectations and a second indication was added, requiring salesforce expansion. Ongoing enhancement.s, including an iPad app and custom KPIs, delivered rapid insights, strong client satisfaction, and a trusted long-term partnership

Join for free to read

White Paper Emerging capabilities for first responders: Forecasting…

Report Emerging Technologies- 2024 Vision Report

Report LEADING EDGE - GENAI & THE EMERGING WORKFORCE TRANSFORMATION

Case Study Emerging Technologies

More from IQVIA

Vendor Sheet IQ20/20 SMART Flexview Reporting Tool

Case Study Data Management Set to Launch

Case Study How Emerging Biopharma Companies Can Successfully Launch Their…

Vendor Sheet IQVIA Launch Tracker Dashboard

Case Study

IQ20/20 Supports Emerging Biopharma’s First Launch

IQ20/20 Supports Emerging Biopharma’s First Launch

You Might Also Like

More from IQVIA